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Identification of methionine aminopeptidase-2
(MetAP-2) as the molecular target of the antiangio-
genic compound TNP-470 has sparked interest in
N-terminal Met excision’s (NME) role in endothelial
cell biology. In this regard, we recently demonstrated
that MetAP-2 inhibition suppresses Wnt planar cell
polarity (PCP) signaling and that endothelial cells
depend on this pathway for normal function. Despite
this advance, the substrate(s) whose activity is
altered upon MetAP-2 inhibition, resulting in loss of
Wnt PCP signaling, is not known. Here we identify
the small G protein Rab37 as a MetAP-2-specific
substrate that accumulates in the presence of TNP-
470. A functional role for aberrant Rab37 accumula-
tion in TNP-470’s mode of action is demonstrated
using a Rab37 point mutant that is resistant to
NME, because expression of this mutant pheno-
copies the effects of MetAP-2 inhibition on Wnt
PCP signaling-dependent processes.
INTRODUCTION
Angiogenesis is the process of forming new blood vessels from
the existing vasculature and is essential for normal development
(Carmeliet, 2005). However, because inappropriate blood vessel
formation contributes to many disease processes including
rheumatoid arthritis, endometriosis, diabetic retinopathy, mac-
ular degeneration, and tumorigenesis, antiangiogenic therapy
has broad clinical potential (Folkman, 2007). The microbial
metabolite fumagillin and its synthetic derivatives (e.g., TNP-
470) are potent, first-in-class small-molecule angiogenesis
inhibitors with established efficacy in vivo (Ingber et al., 1990;
Kruger and Figg, 2000). Affinity chromatography with bio-1300 Chemistry & Biology 18, 1300–1311, October 28, 2011 ª2011 Etinylated fumagillin derivatives identified the metalloprotease
methionine aminopeptidase-2 (MetAP-2), one of two proteins
responsible for N-terminal methionine excision (NME) in eukary-
otes, as the molecular target responsible for fumagillin/TNP-
470’s antiangiogenic activity (Griffith et al., 1997; Sin et al.,
1997; Yeh et al., 2006). This discovery has stimulated interest
in the exquisite sensitivity of endothelial cells to loss of MetAP-2
activity, relative to nonendothelial cell types, and inspired devel-
opment of several novel structural classes of MetAP-2 inhibitors
(Arico-Muendel et al., 2009; Marino et al., 2007; Wang et al.,
2007, 2008).
Recently, our lab demonstrated that MetAP-2 inhibition
suppresses Wnt planar cell polarity (PCP) signaling (Zhang
et al., 2006), an intracellular signaling network activated by
binding of secreted Wnt proteins to Frizzled (Fz) seven-pass
transmembrane receptors (Angers and Moon, 2009). Wnt-Fz
complexes transduce signaling through the intracellular scaf-
folding protein Dishevelled (Dvl), leading to activation of various
downstream effectors (Angers andMoon, 2009). MetAP-2 inhibi-
tion specifically suppresses activation of downstream effectors
of Wnt PCP signaling such as c-Jun N-terminal kinase and the
small G protein RhoA (Zhang et al., 2006). We, and others,
have also demonstrated that normal endothelial cell function
depends on finely balanced Wnt PCP signaling; expressing a
dominant-negative Dishevelled mutant, knockdown of wnt5, or
expression of a constitutively active form of theWnt PCP effector
DAAM1 suppresses endothelial cell proliferation and impairs
angiogenesis in vivo (Cheng et al., 2008; Cirone et al., 2008; Ju
et al., 2010; Masckaucha´n et al., 2006).
Although several preferential MetAP-2 substrates (e.g.,
GAPDH, cyclophilin A, and thioredoxin-1) have been identified,
N-terminal Met retention on these proteins does not contribute
to the effects of MetAP-2 inhibition on Wnt PCP signaling and
angiogenesis (Wang et al., 2008;Warder et al., 2008). Here, using
an unbiased N-terminal positional proteomics screen, we iden-
tify Rab37 as a preferential MetAP-2 substrate that aberrantly
accumulates in the presence of TNP-470 and, when overex-
pressed, phenocopies the effects of MetAP-2 inhibition on Wntlsevier Ltd All rights reserved
Figure 1. Identification of MetAP-2 Substrates by N-Terminal Positional Proteomics
MPE cells cultured in media containing stable heavy isotope-labeled arginine ([13C6]Arg) were treated with TNP-470, whereas vehicle-treated cells were
maintained in the presence of [12C6]Arg. Following cell lysis, soluble fractions from the two treatment conditions were pooled and N-terminal peptides were
isolated by the following reaction sequence: (1) proteomic chemical acetylation of primary amines on N termini and lysine-residue side chains; (2) tryptic
proteolysis to generate blocked N-terminal peptides and internal peptides with newly exposed reactive a-amino groups; and (3) removal of these internal
peptides by reaction with an immobilized amine capture reagent. Isolated N-terminal peptides can then be identified by LC-MS/MS and the role of MetAP-2 in
N-terminal Met excision determined by comparing abundance of the heavy (TNP-470-treated) versus light (vehicle-treated) peptides.
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Wnt PCP Signaling Disruption by Rab37PCP signaling-dependent processes such as endothelial cell
proliferation/network formation and zebrafish embryogenesis.
RESULTS
Identification of Preferential MetAP-2 Substrates
by N-Terminal Proteomics
Given that methionine aminopeptidases are responsible for
NME, we reasoned that an N-terminal positional proteomics
screen would be well suited for identification of proteins that
retain their N-terminal Met residue following MetAP-2 inhibition.
Our N-terminal positional proteomics approach (see Figure 1)
generates an enriched pool of N-terminal peptides that can
more easily be identified by liquid chromatography-tandem
mass spectroscopy (LC-MS/MS) than global proteomic prepara-
tions (McDonald et al., 2005).Chemistry & Biology 18, 1300–1For this study, murine pulmonary endothelial (MPE) cells were
cultured in media containing stable heavy isotope-labeled argi-
nine ([13C6]Arg) for seven passages before exposure to TNP-
470 (50 nM, 16 hr). A control set of MPE cells was maintained
in unlabeled media and then treated with vehicle. Following
cell lysis, soluble fractions from the two treatment conditions
were pooled and used to generate N-terminal peptide prepara-
tions. Whereas stable isotope-labeled (‘‘heavy’’) N-terminal pep-
tides are derived from TNP-470-treated cells, the unlabeled
(‘‘light’’) counterparts from vehicle-treated cells should show
normal processing. In this experiment, essentially all of the iden-
tified N-terminal peptides produced LC-MS/MS signals of equiv-
alent intensity, suggesting that MetAP-2 is redundant for NME
for most proteins. In contrast, abundance of the heavy (TNP-
470-treated) versus light (vehicle-treated) N-terminal peptide
corresponding to glyceraldehyde 3-phosphate dehydrogenase311, October 28, 2011 ª2011 Elsevier Ltd All rights reserved 1301
Figure 2. Rab37 Is a Novel MetAP-2 Substrate
(A and B) LC-MS analysis of N-terminal peptides from MPE cells differentially labeled with [13C6]Arg before treatment with vehicle or TNP-470 (50 nM, 16 hr).
Unprocessed N-terminal tryptic peptides are highlighted in the ovals. Note the peak height difference in the light, vehicle-treated, and heavy (i.e., [13C6]Arg-
labeled) TNP-470-treated peptides for the known MetAP-2 substrate GAPDH. No light, vehicle-treated N-terminal tryptic peptide was detected for the novel
MetAP-2 substrate Rab37, suggesting that this protein is destabilized by NME.
(C) Diagram of Rab37 constructs used in this study.
(D) Whole-cell lysates from HEK293T cells transiently transfected with WT- or T2E-Rab37 (50 ng) or empty vector followed by incubation with vehicle or TNP-470
(50 nM, 16 hr) were immunoblotted with specific antibodies as indicated.
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data are consistent with previous reports indicating that GAPDH
is preferentially processed by MetAP-2 (Turk et al., 1999; Wang
et al., 2008), and suggest N-terminal positional proteomics is
a viable approach to identify novel MetAP-2 substrates.
Rab37 Is a Novel MetAP-2 Substrate
In addition to GAPDH, another protein that displayed an isotope-
labeling pattern consistent with MetAP-2 processing was the
low-molecular weight G protein Rab37 (Figure 2B). In fact, unla-
beled N-terminal peptide was not detected in this case, suggest-
ing that Rab37 is destabilized by NME and, thus, accumulates in
the presence of TNP-470. As a first step, we sought to indepen-
dently confirm this result by determining whether Rab37 accu-
mulates upon MetAP-2 inhibition. Because available antibodies
were unable to detect either endogenous or ectopically ex-
pressed Rab37, we transiently transfected human embryonic
kidney (HEK) 293T cells with a Rab37 construct containing
a FLAG epitope tag beginning at N+3 position (WT-Rab37),
thereby preserving the endogenous N terminus of Rab37 (Fig-
ure 2C). In vehicle-treated cells, WT-Rab37 was present at low
levels, whereas inhibition of MetAP-2 with TNP-470 led to a large
(>10-fold) increase in Rab37 abundance (Figure 2D). To deter-
mine whether TNP-470-induced Rab37 accumulation is directly1302 Chemistry & Biology 18, 1300–1311, October 28, 2011 ª2011 Erelated to N-terminal Met retention, we transiently expressed
equivalent amounts of WT-Rab37 (50 ng) or a mutant (T2E-
Rab37) that is completely resistant to MetAP-2 processing due
to substitution of the penultimate N-terminal Thr to Glu (Xiao
et al., 2010). Basal levels of this MetAP-2-resistant mutant
are >10-fold higher than WT-Rab37, and did not further increase
in the presence of TNP-470 (Figure 2D). Importantly, abundance
of T2E-Rab37 was essentially equivalent to that of WT-Rab37 in
TNP-470-treated cells (Figure 2D), suggesting that T2E-Rab37 is
stabilized relative to the wild-type protein due to inhibition of
NME. These data, along with the results of our N-terminal pro-
teomic study, indicate that Rab37 is a novel MetAP-2 substrate
that is destabilized by NME and, thus, accumulates in the pres-
ence of TNP-470.
Subcellular Localization of Rab37 in Endothelial Cells
Rab GTPases are members of the Ras superfamily of low-
molecular weight G proteins that function as key regulators of
intracellular trafficking in eukaryotic cells (for reviews, see Pfeffer
and Aivazian, 2004; Stenmark, 2009). The >60 Rab proteins in
metazoan cells are localized to specific organelles, where they
regulate vesicular transport by recruiting effectors such as
lipid kinases/phosphatases, motor proteins, and membrane-
tethering factors (Grosshans et al., 2006). Rab37 has beenlsevier Ltd All rights reserved
Figure 3. Localization of Rab37 GTPase
Cycle Mutants Suggests a Role in Plasma
Membrane-to-Golgi Trafficking
(A) HUVE cells electroporated with WT- or T2E-
Rab37 were cultured on gelatin-coated slides fol-
lowed by staining with antibodies for FLAG and the
Golgi marker Giantin.
(B) HEK293T cells transiently transfected with
WT-Rab37, Rab37-Q89L, or Rab37-T43N were
cultured on poly-L-lysine-coated slides followed
by staining with antibodies specific for FLAG and
the Golgi marker Giantin.
The scale bars represent 10 mm. See also Figures
S1–S3.
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Wnt PCP Signaling Disruption by Rab37reported to associate with secretory granules in mast cells and
pancreatic b-cells (Brunner et al., 2007; Masuda et al., 2000),
leading to the assumption that it plays a role in exocytosis
(Stenmark, 2009). However, Rab37 was recently identified in a
proteomic analysis of the endoplasmic reticulum-Golgi interme-
diate compartment of hepatocarcinoma cells (Breuza et al.,
2004). Given these conflicting results, we sought to define the
subcellular localization ofRab37 in endothelial cells by transiently
expressing WT-Rab37 in human umbilical vein endothelial
(HUVE) cells. In these cells, WT-Rab37 displayed a perinuclear,
crescent-shaped distribution suggestive of localization to the
Golgi, which is further supported by colocalization with the Golgi
marker Giantin (Figure 3A). Transiently expressed T2E-Rab37Chemistry & Biology 18, 1300–1311, October 28, 2011 ªwas detected more readily than wild-
type protein (i.e., photodetector sensi-
tivitywas increased forWT-Rab37 relative
to T2E-Rab37 to obtain similar intensity
staining), and was also localized to a peri-
nuclear compartment closely associated
with the Golgi resident protein Giantin
(Figure 3A). Thus, unlike abundance, lo-
calization of Rab37 to the Golgi is not
affected by N-terminal Met retention.
To determinewhether transient expres-
sion of any Rab protein in endothelial cells
is sufficient to induce accumulation in
the Golgi, HUVE cells were cotransfected
with WT-Rab37 and RFP-Rab5, a Rab
protein associated with early endosomes
(Bucci et al., 1992). Whereas RFP-Rab5
displayed cytosolic, vesicular staining
consistent with localization to early endo-
somes, Rab37 was again detected in
perinuclear clusters (see Figure S1 avail-
able online). In addition, wild-type Rab37
bearing an N-terminal GFP colocalized
with the Golgi resident protein GM130
when expressed in MPE cells (Figure S2),
which indicates that Rab37 is localized to
the Golgi in endothelial cells derived from
different species and anatomical origins.
Trafficking of Rab proteins from loading
to docking membranes is associated with
a transition from GDP to GTP binding(Stenmark, 2009). Because the catalytic site of Rab proteins is
highly conserved, well-characterized mutants can be prepared
in which the GTP (Q89L for Rab37)- or GDP (T43N for Rab37)-
bound state is stabilized (Masuda et al., 2000). Determining the
subcellular localization of these GTPase cycle mutants can
provide clues about the intracellular trafficking processes regu-
lated by a particular Rab protein (Stenmark, 2009). Expression
of Rab37-T43N could not be detected in transiently transfected
HUVE or MPE cells, preventing analysis of the subcellular distri-
bution of Rab37 GTPase cycle mutants in endothelial cells. In
HEK293T cells, WT-Rab37 and the GTP-stabilized mutant are
primarily detected in a perinuclear compartment that colocalizes
with Giantin (Figure 3B), and display little overlap with other2011 Elsevier Ltd All rights reserved 1303
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the endoplasmic reticulum (Figure S3). In contrast, a significant
portion of Rab37-T43N staining was detected at the plasma
membrane in this cell type (Figure 3B). These data indicate that
wild-type Rab37 is localized to the Golgi in both endothelial
and nonendothelial cell types, where it is likely to play a role in
retrograde transport from the plasma membrane.
Aberrant Rab37 Accumulation Selectively Disrupts
Endothelial Cell Function
Given that Rab37 levels increase in the presence of TNP-470, it is
intriguing that a number of Rab proteins or their effectors have
been shown to regulate Wnt PCP signaling (Lee et al., 2007;
Mottola et al., 2010; Pataki et al., 2010; Purvanov et al., 2010).
Thus, we hypothesized that aberrant accumulation of Rab37
following inhibition of MetAP-2 may act via a ‘‘gain-of-function’’
mechanism to disrupt Wnt PCP signaling and, as a result, endo-
thelial cell homeostasis. We evaluated this model by comparing
the effects of stably expressing WT- or T2E-Rab37 in HEK293T
versus HUVE cells to determine whether accumulation of
Rab37 ‘‘phenocopies’’ the endothelial cell-selective antiprolifer-
ative activity of MetAP-2 inhibition. HEK293T and HUVE lines
stably expressingWT- or T2E-Rab37 or a GFP control were gen-
erated by infection with retroviral expression constructs fol-
lowed by puromycin selection. T2E-Rab37 was observed at
z3-fold higher levels than wild-type protein in both HUVE and
HEK293T cells (Figure 4A). These data are consistent with tran-
sient expression in HEK293T cells (Figure 2D), and suggest that
N-terminal Met retention also promotes aberrant Rab37 accu-
mulation in endothelial cells.
Stable expression of WT- or T2E-Rab37 did not significantly
alter the proliferative capacity of HEK293T cells (Figure 4B).
Although HUVE cells stably expressing WT-Rab37 displayed
a modest (z15%) decrease in [3H]thymidine incorporation, this
effect did not achieve statistical significance. In contrast, stable
expression of T2E-Rab37 results in an approximately 50% re-
duction in proliferative capacity (Figure 4B), a change that
was not associated with increased cell death as measured by
vital dye exclusion (data not shown). To examine whether the
growth-inhibitory effect of T2E-Rab37 expression in HUVE cells
results from locating the FLAG epitope tag near the N terminus,
we prepared untagged wild-type Rab37 and the T2E mutant as
well as constructs containing a FLAG epitope tag 16 residues
proximal to the C terminus, which is not predicted to disrupt
the C-terminal prenylation motif (Figure S4A). These constructs
were stably expressed in HUVE cells via retroviral infection/
puromycin selection (Figure S4B). Consistent with N-terminal
FLAG epitope-tagged Rab37, expression of wild-type untagged
or C-terminal tagged Rab37 did not alter the proliferative
capacity of HUVE cells (Figure S4C). In contrast, [3H]thymidine
incorporation was reduced by nearly 50% and 30% in HUVE
cells expressing the untagged or C-terminal tagged T2E-
Rab37, respectively, relative to GFP control cells (Figure S4C).
Along with reduced basal proliferative capacity, HUVE cells
stably expressing T2E-Rab37 were approximately 3-fold more
sensitive to TNP-470-induced growth arrest than control cells
expressing GFP, with EC50 values of 60 ± 10 versus 180 ± 20
pM, respectively (Figure 4C). In contrast, expression of WT-
Rab37 did not affect the EC50 for TNP-470-induced growth1304 Chemistry & Biology 18, 1300–1311, October 28, 2011 ª2011 Earrest in HUVE cells (Figure 4C). Together, the ability of T2E-
Rab37 to selectively suppress endothelial cell proliferation and
to sensitize HUVE cells to TNP-470 supports a model in which
N-terminal Met retention on Rab37 contributes to growth arrest
following MetAP-2 inhibition.
In vivo, angiogenesis involves migration and intercellular
communication between endothelial cells in addition to prolifer-
ation (Carmeliet, 2005). Hence, the antiangiogenic effects of
MetAP-2 inhibition suggest that aberrant Rab37 accumulation
might also perturb these processes. Organization of endothelial
cells into coordinated tubular networks when cultured on Matri-
gel basement membrane is a quantitative in vitro proxy of angio-
genesis (Staton et al., 2004). As shown in Figure 4D, HUVE cells
stably expressing GFP formed similar numbers of cell extensions
as a mock-infected control (108 ± 10 versus 89 ± 8 extensions/
field-of-view, respectively), which indicates that retroviral
infection/puromycin selection does not impair this process. By
contrast, HUVE cells stably expressing WT- or T2E-Rab37
formed 36 ± 6 or 15 ± 4 extensions/field-of-view, respectively,
which corresponds to a 60% or 85% decrease relative to GFP
control (Figure 4D). Because endothelial cell network formation
correlates with angiogenic potential (Staton et al., 2004), these
data suggest that aberrant accumulation of Rab37 plays a role
in the antiangiogenic effects of MetAP-2 inhibition.
Activation of Wnt PCP Signaling Suppresses
Rab37-Induced Growth Arrest
Given that expression of T2E-Rab37 phenocopies the inhibitory
effects of fumagillin/TNP-470 on Wnt PCP signaling-dependent
processes in endothelial cells, we next explored whether
Rab37-induced growth arrest could be rescued by constitutive
activation of this signaling cascade. To address this question,
HUVE cells stably expressing a Dvl2 deletion mutant (DDIX-
Dvl2) or the corresponding empty vector were generated by
retroviral infection followed by zeocin selection (Figure 4E). Dele-
tion of the Dishevelled amino-terminal DIX domain results in
selective activation of Wnt PCP signaling in an Fz-independent
manner (Heisenberg et al., 2000; Tada and Smith, 2000; Walling-
ford and Habas, 2005), and expression of DDIX-Dvl2 rescues
endothelial cells from TNP-470-induced growth arrest (Zhang
et al., 2006). Next, HUVE cells expressing DDIX-Dvl2 or the
corresponding empty vector were infected with retroviruses
encoding GFP or T2E-Rab37 and stable integrants selected
with puromycin (Figure 4E). Similar to Figure 4B, expression of
T2E-Rab37 reduced [3H]thymidine incorporation by z40%
compared to GFP in HUVE cells first infected with empty vector
(Figure 4F). Whereas expression of DDIX-Dvl2 decreased [3H]
thymidine incorporation by z50% relative to empty vector,
T2E-Rab37 did not further reduce proliferative capacity of
HUVE cells expressing this construct (Figure 4F). The ability of
DDIX-Dvl2 to render HUVE cells resistant to T2E-Rab37-induced
growth arrest suggests that disruption of Wnt PCP signaling
contributes to the deleterious effects of aberrant Rab37 accumu-
lation on normal endothelial cell function.
Rab37 Knockdown Selectively Suppresses Endothelial
Cell Proliferation
Normal development requires finely balanced Wnt PCP sig-
naling; both knockdown and overexpression of Wnt PCPlsevier Ltd All rights reserved
Figure 4. Aberrant Rab37 Accumulation Disrupts Endothelial Cell Function
(A) Whole-cell lysates from HUVE or HEK293T cells stably expressing GFP or WT- or T2E-Rab37 were immunoblotted with specific antibodies as indicated.
(B) Effect of stably expressing GFP or WT- or T2E-Rab37 on [3H]thymidine incorporation in HEK293T cells (black bars) or HUVE cells (white bars).
(C) HUVE cells stably expressing GFP (C, solid line), WT-Rab37 (-, dashed line), or T2E-Rab37 (:, dotted line) were treated with the indicated concentrations of
TNP-470 for 20 hr followed by labeling with [3H]thymidine (20 mCi/ml; 4 hr) before harvesting of nuclei.
(D) Stable retroviral infection with WT- or T2E-Rab37 suppresses network formation in HUVE cells plated on Matrigel relative to cells stably infected with GFP or
mock-infected cells. The scale bar represents 100 mm.
(E) Whole-cell lysates from HUVE cells stably expressing HA-DDIX-Dvl2 along with GFP or T2E-Rab37 were immunoblotted with specific antibodies as indicated.
(F) Effect of stably expressing GFP (black bars) or T2E-Rab37 (white bars) on [3H]thymidine incorporation in HUVE cells previously infected with HA-DDIX-Dvl2 or
the corresponding vector control.
All values are mean ± SD of nR 3 independent experiments. See also Figure S4.
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Wnt PCP Signaling Disruption by Rab37proteins (e.g., Dishevelled) disrupt this pathway, leading to
abnormal phenotypes (Seifert and Mlodzik, 2007; Wallingford
et al., 2000). Given that aberrant accumulation of Rab37Chemistry & Biology 18, 1300–1suppresses Wnt PCP-dependent processes, we next asked
what effect depleting Rab37 has on endothelial cell proliferation.
For this experiment, Rab37 expression was stably reduced in311, October 28, 2011 ª2011 Elsevier Ltd All rights reserved 1305
Figure 5. Rab37 Is Essential for Endothelial Cell Proliferation
(A) Infecting HEK293 cells stably expressing WT-Rab37 with lentiviral shRNA
constructs targeting Rab37 reduced levels of this protein relative to a non-
targeting scramble shRNA as detected by immunoblotting with specific anti-
bodies as indicated.
(B) Effect of stably expressing lentiviral shRNA constructs targeting Rab37 on
[3H]thymidine incorporation in HEK293 cells (black bars) or HUVE cells (white
bars) versus a nontargeting scramble shRNA.
(C) HUVE cells stably expressing Rab37-targeting shRNA #1 (6, dotted line) or
#2 (,, dashed line) or a nontargeting scramble shRNA (B, solid line) were
treated with the indicated concentrations of TNP-470 for 20 hr followed by
labeling with [3H]thymidine (20 mCi/ml; 4 hr) and harvesting of nuclei.
All values are mean ± SD of nR 3 independent experiments.
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Wnt PCP Signaling Disruption by Rab37HUVE cells by infection with two separate lentiviral shRNA
constructs targeting Rab37 or a nontargeting scramble shRNA
construct followed by puromycin selection. Because endoge-
nous Rab37 could not be detected in HUVE cells, we simulta-
neously infected a HEK293 clone stably expressing WT-Rab37,
which resulted in a >90% decrease in Rab37 protein levels rela-
tive to the nontargeting scramble shRNA (Figure 5A). Although
near-complete knockdown of Rab37 modestly inhibited prolifer-
ation of HEK293 cells measured in terms of [3H]thymidine incor-
poration (Figure 5B), this trend failed to achieve statistical
significance. In contrast, stable knockdown of Rab37 in HUVE
cells decreased [3H]thymidine incorporation >75% relative to
the scramble shRNA control (Figure 5B). Levels of [3H]thymidine
incorporation in HUVE cells expressing the shRNA scramble
sequence are reproducibly z2-fold higher than those stably
infected with GFP (Figure 5C versus Figures 4C and 4E), a
decrease likely attributable to differential effects of lenti- versus
retroviral infection, respectively. Although growth arrest induced
byRab37depletion inHUVEcells substantially obscures the anti-
proliferative effects of MetAP-2 inhibition, [TNP-470] R1 nM
reduced [3H]thymidine incorporation z2-fold in Rab37 knock-
down HUVE cells (Figure 5C). Although these data suggest
that N-terminal Met retention on additional MetAP-2 substrates
may contribute to growth arrest induced by fumagillin/
TNP-470, the endothelial cell-selective antiproliferative effect
of Rab37 knockdown is consistent with this protein playing
a previously unappreciated role in Wnt PCP signaling in this
cell type.
Effect of Rab37Expression onZebrafishEmbryogenesis
Wnt PCP signaling plays a regulatory role in convergence-
extension (CE) movements during vertebrate gastrulation
(Seifert and Mlodzik, 2007). For instance, loss-of-function
mutations in the wnt5 locus lead to a characteristic truncated,
kinked pipetail (ppt) morphology and accompanying vascular
defects during zebrafish embryogenesis (Cirone et al., 2008;
Rauch et al., 1997). An analogous phenotype is observed in
zebrafish embryos, where MetAP-2 function is reduced by
TNP-470 or downregulation of metap2 with antisense morpho-
lino oligonucleotides (Cirone et al., 2008; Zhang et al., 2006). To
determine whether Rab37 expression phenocopies the effects
of MetAP-2 inhibition on CE, zebrafish embryos were injected
with equivalent amounts of RNA encoding untagged wild-type
Rab37 or the MetAP-2-resistant T2E mutant. For T2E-Rab37,
the injected embryos displayed a moderately penetrant (z25%
of embryos) phenotype characterized by a shortened, kinked
tail reminiscent of the morphology resulting from downregula-
tion of wnt5 ormetap2 (Figure 6A; Table 1). Careful examination
of the T2E-Rab37-injected embryos revealed formation of
C-shaped somites and undulations in the notochord, which
contrasts with the straight notochord and chevron-shaped
somites in control embryos (Figure 6A). Although similar phe-
notypes were observed in WT-Rab37-injected embryos,
these effects were both milder and less penetrant (Figure 6A;
Table 1).
To determine whether molecular evidence of Wnt PCP
signaling loss accompanied these morphological changes, we
coinjected embryos with RNA encoding membrane-localized
mCherry and Centrin-GFP in the presence or absence of1306 Chemistry & Biology 18, 1300–1311, October 28, 2011 ª2011 Elsevier Ltd All rights reserved
Figure 6. Rab37 Expression Phenocopies
Loss of Wnt PCP Signaling during Zebrafish
Development
(A) Uninjected (control) zebrafish embryos 24 hr
postfertilization display a straight notochord char-
acterized by the presence of ‘‘chevron-shaped’’
somites. Injection with wild-type Rab37 RNA re-
sults in slight shortening of the anterior-posterior
axis, whereas embryos injected with T2E-Rab37
RNA results in notochord undulations and forma-
tion of ‘‘C-shaped’’ somites (black arrows) leading
to severe shortening and kinking of the anterior-
posterior axis. Additionally, embryos injected with
T2E-Rab37 RNA display an accumulation of blood
posterior to the yolk extension (black chevron),
which suggests impaired vasculogenesis.
(B) Confocal images of the neural floorplate of ze-
brafish embryos injectedwithmembrane-localized
mCherry and Centrin-GFP in the presence/
absence of T2E-Rab37. Centrin-GFP is localized
to the posterior membrane of control-injected
embryos (white arrows), whereas overall morpho-
genesis and Centrin localization is disrupted in
embryos injected with T2E-Rab37 RNA. The scale
bar represents 10 mm.
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Wnt PCP Signaling Disruption by Rab37T2E-Rab37. Centrin-GFP is a viable marker for basal bodies at
the base of cilia projecting from neural floorplate glia (Piel
et al., 2000), andWnt PCP signaling is implicated in polarized cil-
iogenesis in this organ during zebrafish embryogenesis
(Borovina et al., 2010). In control-injected embryos, the cells of
the neural floorplate show an ordered, interlaced pattern with
many basal bodies docked at the posterior membrane (Fig-
ure 6B). In contrast, the morphological abnormalities in T2E-
Rab37-injected embryos were accompanied by loss of neural
floorplate organization and random localization of Centrin-GFP
(Figure 6B), both effects that are consistent with aberrant
Rab37 levels acting to compromise Wnt PCP signaling.
We previously demonstrated that perturbation of Wnt PCP
signaling due to wnt5 loss-of-function alleles or overexpression
of the Wnt PCP effector DAAM1 leads to vascular defects during
zebrafish embryogenesis (Cirone et al., 2008; Ju et al., 2010).
Similarly, embryos injected with T2E-Rab37, but not wild-
type protein, were characterized by an accumulation of blood
posterior to the yolk extension, which is indicative of defective
vasculogenesis (Figure 6A). The increased severity of the devel-Table 1. Quantification of Developmental Defects Caused by
Aberrant Rab37 Expression during Zebrafish Embryogenesis
RNA Wild-Type-like
C-Shaped
Somites
Undulated
Notochord Morphant (%)
Control 77 — 1 1
WT-Rab37 100 8 5 11
T2E-Rab37 95 20 14 26
Chemistry & Biology 18, 1300–1311, October 28, 2011 ªopmental abnormalities in T2E- versus
WT-Rab37-injected embryos is consis-
tent with our endothelial cell culture data
and suggests that N-terminal Met reten-tion promotes Rab37 accumulation and disruption of Wnt PCP
signaling-dependent processes in a variety of contexts.
DISCUSSION
Owing to the subtlety of the structural change resulting from
N-terminal Met retention, identification of preferential MetAP-2
substrates has proven challenging using global proteomics tech-
niques. Here we employ a positional proteomics strategy to
enrich N-terminal peptides, enabling specific analysis of how
MetAP-2 inhibition affects both protein abundance and
N-terminal amino acid composition in endothelial cells. Despite
this highly sensitive and focused approach, levels of nearly all
the detected N-terminal peptides were not altered by TNP-470
treatment, which suggests that MetAP-2 specifically processes
a very small subset of proteins. A more prominent role for
MetAP-1 in bulk NME is consistent with the dramatic growth-
inhibitory effect of deleting map1 in yeast, relative to the mild
phenotype observed in Dmap2 strains (Li and Chang, 1995).
However, in this study, TNP-470 treatment led to N-terminal
Met retention on Rab37 (N terminus: Met-Thr-Gly N terminus)
as well as on the previously identified substrate GAPDH (N
terminus: Met-Val-Lys), which is consistent with recent bio-
chemical analysis of NME indicating that proteins beginning
with Met-Thr or Met-Val are preferentially processed by
MetAP-2 (Xiao et al., 2010). In accordance with previous studies,
TNP-470 treatment did not significantly elevate GAPDH levels
(Turk et al., 1999; Wang et al., 2008). In contrast, Rab37 abun-
dance is dramatically increased by MetAP-2 inhibition, which
appears to be a direct consequence of N-terminal Met retention2011 Elsevier Ltd All rights reserved 1307
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at equivalent levels as wild-type protein in the presence of
TNP-470. The differential accumulation of GAPDH versus
Rab37 in response to TNP-470 is likely related to the turnover
rate of each protein. Whereas the subtle effects of MetAP-2 inhi-
bition on GAPDH abundance are consistent with the low rate of
GAPDH turnover (t1/2 z38 hr) (Franch et al., 2001), the pro-
nounced increase in levels of Rab37 bearing an N-terminal Met
residue in TNP-470-treated endothelial cells suggests this pro-
tein is degraded/resynthesized at a significantly faster rate.
A recent extension of Varshavsky’s N-End-Rule indicates
that acetylated N-terminal Met, Ala, Ser, Thr, Cys, and Val resi-
dues are specifically recognized by the E3 ubiquitin ligase
Doa10 (Teb4 in metazoans), leading to degradation by the
ubiquitin-proteasome system (Hwang et al., 2010). Acetylation
of N-terminal Met residues by the NatB complex requires the
presence of charged or bulky, hydrophobic penultimate resi-
dues, which also prevent NME (Arnesen et al., 2009). In contrast,
N-terminal Ala, Ser, Thr, Cys, and Val residues revealed by NME
are acetylated by the NatA complex (Arnesen et al., 2009).
Perhaps retention of the N-terminal Met residue on Rab37
following MetAP-2 inhibition prevents acetylation by NatA and,
as a result, Doa10/Teb4-mediated proteasomal degradation.
Consistent with this model, endothelial cell-specific knockout
of the NatA component NAA15, which should suppress Rab37
N-terminal acetylation, results in vascular defects in mice (Wall
et al., 2004).
Genetic studies in model organisms such as Drosophila have
identified ‘‘core’’ PCP proteins whose asymmetric cellular local-
ization is required for normal formation of polarized tissues
across phyla (Seifert and Mlodzik, 2007). Perhaps not surpris-
ingly given their central role in intracellular trafficking, an
emerging body of evidence implicates Rab proteins in Wnt
PCP signaling. For example, Rab23 loss-of-function alleles
induce trichome misorientation in Drosophila wings, and knock-
down of XRab40 in Xenopus embryos disrupts CE movements
during embryogenesis (Lee et al., 2007; Pataki et al., 2010).
Moreover, normally functioning Wnt PCP signaling requires
precisely coordinated intracellular trafficking, as evidenced by
the multiple-wing hair phenotype observed in Drosophila ex-
pressing a gain-of-function, GTP-stabilized Rab11-QL mutant,
which disrupts Wnt PCP signaling due to unchecked recycling
of Fz receptors to the plasma membrane (Purvanov et al.,
2010). These findings support a model whereby aberrant accu-
mulation of Rab37 following MetAP-2 inhibition disrupts Wnt
PCP signaling and, as a result, compromises endothelial cell
function. Although expression of T2E-Rab37 selectively sup-
presses endothelial cell proliferation, this reduction is less
pronounced than the effects on endothelial cell network forma-
tion and zebrafish embryogenesis. This difference may imply
that N-terminal Met retention on additional MetAP-2 substrates
contributes to the antiproliferative activity of fumagillin/TNP-
470. Alternatively, the inhibitory effects of T2E-Rab37 expression
on Wnt PCP signaling may be more profound in assays that
better recapitulate the complex, multicellular processes under-
lying angiogenesis in vivo.
The subcellular distribution of the Rab37 GTPase cycle
mutants suggests a role for this protein in plasma membrane-
to-Golgi trafficking. Normal function of many core Wnt PCP1308 Chemistry & Biology 18, 1300–1311, October 28, 2011 ª2011 Esignaling components (e.g., Fz and Dvl) depends on their locali-
zation to the plasma membrane (Seifert and Mlodzik, 2007). As
such, it is tempting to speculate that aberrant accumulation of
Rab37 might, opposite of the mechanism induced by Rab11-
QL mutants, sequester Wnt PCP components in the Golgi,
thereby disrupting normal signaling. Regardless of the mecha-
nism involved, the discovery and functional validation of Rab37
as a novel MetAP-2-specific substrate provides new insight
into fumagillin/TNP-470’s mode of action and identifies a previ-
ously unrecognized regulatory role for this protein in Wnt PCP
signaling.
SIGNIFICANCE
The microbial metabolite fumagillin and its synthetic deriva-
tives (e.g., TNP-470) possess promising antiangiogenic and
antitumor activities derived from exquisite cell type-selec-
tive arrest of endothelial cell proliferation. The metallopro-
tease methionine aminopeptidase-2 (MetAP-2), one of two
proteins that mediate N-terminal Met excision, is the molec-
ular target responsible for fumagillin/TNP-470’s antiangio-
genic activity. Recently, we demonstrated that MetAP-2 in-
hibition suppresses Wnt planar cell polarity (PCP) signaling
and that disruption of this pathway impairs endothelial
cell function, leading to vascular defects during zebrafish
embryogenesis. Despite this advance, the identity of the
MetAP-2 substrate(s) whose function is altered in the pres-
ence of fumagillin/TNP-470 resulting in loss of Wnt PCP
signaling has remained enigmatic. Here we employed an
N-terminal positional proteomics strategy to screen for
MetAP-2-specific substrates. This unbiased approach iden-
tified Rab37 as a protein whose N-terminal Met-retained
form is highly enriched in endothelial cells followingMetAP-2
inhibition. Significantly, expression of a Rab37 point mu-
tant that is resistant to MetAP-2 processing phenocopies
the inhibitory effects of fumagillin/TNP-470 on Wnt PCP
signaling-dependent processes such as endothelial cell
proliferation/network formation as well as vascularization
during zebrafish embryogenesis. These findings position
aberrant Rab37 accumulation as a critical component of
the mechanism underlying the antiangiogenic effects of
MetAP-2 inhibition. Perhaps more generally, identification
of Rab37 as a regulator of Wnt PCP signaling corresponds
to an emerging body of evidence implicating Rab proteins
in the normal organization/function of theWnt PCP signaling
machinery. Therefore, further study of how aberrant Rab37
accumulation disrupts Wnt PCP signaling should provide
fresh insight into how this signaling network regulates endo-
thelial cell function.
EXPERIMENTAL PROCEDURES
Cell Culture
Tissue-culture reagents, including fetal bovine serum (FBS), were obtained
from Invitrogen. Primary HUVE cells were obtained from the Yale University
Vascular Biology and Therapeutics Program and maintained in EGM-2-MV
media (Lonza). HEK293T cells obtained from the American Type Culture
Collection and gp293 retroviral packing cells (BD Biosciences) were cultured
in Dulbecco’s modified Eagle’s medium supplemented with 10% FBS (vol/vol)
andpenicillin (100mg/ml)/streptomycin (100U/ml). Cellswere transfectedusinglsevier Ltd All rights reserved
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For stable expression of WT-Rab37, pCDNA5/FRT/WT-Rab37 was cotrans-
fected in a 1:9 ratiowith pOG4 (FRT plasmid) into 293 FlpIn cells (Invitrogen) fol-
lowedbyselection of stable cloneswith hygromycinB (100mg/ml). For retroviral
infections, pBABE.puro/WT- or T2E-Rab37 or pBABE.ble/HA-DDIX-Dvl2 were
cotransfected in a 1:1 ratiowith pMD2.G (12259; Addgene) into gp293 retroviral
packaging cells. For stable knockdownofRab37, HEK293T cells were cotrans-
fected in a 1:3:3 ratio with pMD2.G and psPAX2 (12260; Addgene) along with
pLKO shRNA vectors targeting Rab37 (RHS4552-NM_001006638; Open Bio-
systems) or a nontargeting scramble shRNA (1864; Addgene). After 48 hr, viral
supernatants were harvested, passed through a 0.45 mm filter, and added
directly to the growth media of target cells that had been supplemented with
polybrene (8 mg/ml). After an additional 48 hr, stable integrants were selected
with puromycin (0.5 mg/ml) or zeocin (100 mg/ml). Organic compounds were
dissolved in cell-culture growth media containing%0.5% DMSO.
PCR and Plasmid Construction
pCMV-Sport6/hRab37 (BC016615) was purchased from Open Biosystems.
Wild-type and T2E-Rab37 bearing a FLAG epitope tag at the N+3 position
were generated by PCR amplification using the primer sets (FP: 50-ATATGCG
GATCCGCCACCATGACGGGCGATACAAGGATGACGACGATAAGACGCCA
GGCGCCGTTGCC-30 and RP: 50-ATGCTATCTAGATCACATGAAGGAGCAG
CAGCT-30) or (FP: 50-ATATGCGGATCCGCCACCATGGAAGGCGATTACAAG
GATGACGACGATAAGACGCCAGGCGCCGTTGCC-30 and RP: 50-ATGCTAT
CTAGATCACATGAAGGAGCAGCAGCT-30), respectively, and cloned into the
BamHI/XbaI sites of the pCS2+ vector. Alternatively, WT- and T2E-Rab37
were amplified by PCR using the primer sets (FP: 50-ATATGCTACGTAGCC
ACCATGACGGGCGATTACAAGGATGACGACGATAAGACGCCAGGCGCCG
TTGCC-30 and RP: 50-ATGCTAGTCGACTCACATGAAGGAGCAGCAGCT-30)
or (FP: 50-ATATGCTACGTAGCCACCATGGAAGGCGATTACAAGGATGACGA
CGATAAGACGCCAGGCGCCGTTGCC-30 and RP: 50-ATGCTAGTCGACTCA
CATGAAGGAGCAGCAGCT-30), respectively, and cloned into the SnaBI/SalI
sites of the pBABE.puro retroviral vector. pCDNA5/FRT/WT-Rab37 was gen-
erated by PCR amplifying wild-type Rab37 using the primer set (FP: 50-ATA
TGCGGATCCGCCACCATGACGGGCGATTACAAGGATGACGACGATAAGA
CGCCAGGCGCCGTTGCC-30 and RP: 50-ATGCTAGGGCCCTCACATGAAGG
AGCAGCAGCT-30) and cloned between the BamH1/Aga1 sites of pCDNA5/
FRT (Invitrogen). The Rab37-Q89L and -T43N mutants were generated using
the Stratagene QuikChange Site-Directed Mutagenesis Kit (Agilent Technolo-
gies) from pCS2+/WT-Rab37 using the primer sets (FP: 50-ACACCGC
TGGGCTGGAACGGTTCCG-30 and RP: 50-CGGAACCGTTCCAGCCCAGCG
GTGT-30) or (FP: 50-GAGACACAGGCGTCGGCAAAAATTGTTTCCTGATCCA
ATT-30 and RP: 50-AATTGGATCAGGAAACAATTTTTGCCGACGCCTGTGT
CTC-30), respectively. The pBABE.ble/HA-DDIX-Dvl2 vector was constructed
as described previously (Zhang et al., 2006). Membrane-localized mCherry
and Centrin-GFP cloned into pCS2+ were obtained from S. Holley (Yale
University).
N-Terminal Positional Proteomics Screen
MPE cells were cultured in D-MEM-Flex media (Invitrogen) supplemented with
(heavy) [13C6]Arg or (light) [
12C6]Arg (100 mg/ml) for seven passages and then
treated with TNP-470 (50 nM, 16 hr) or DMSO, respectively. Cells were resus-
pended in isotonic lysis buffer (25 mM Tris [pH 7.4]) and lysed by passage
through a Dounce homogenizer. Cell debris was removed by low-speed
centrifugation (2,000 rpm, 5 min, 4C) followed by isolation of soluble fractions
(S100) by high-speed centrifugation (42,000 rpm, 45 min, 4C). N-terminal
peptides were enriched from S100 fractions and analyzed by LC-MS/MS as
described previously (McDonald et al., 2005).
Immunoblotting
Preparation of whole-cell lysates and immunoblotting was conducted as
describedpreviously (Hineset al., 2010). Antibodiesdetecting theFLAGepitope
tag (F1804) and b-actin (A2228) were obtained from Sigma-Aldrich, whereas
the antibody for the HA epitope tag (3724) was purchased from Cell Signaling.
Immunofluorescence
Briefly, HEK293T cells cultured on poly-L-lysine (100 mg/ml)-coated glass
coverslips were transfected with Rab37 constructs or RFP-Rab5 (14437;Chemistry & Biology 18, 1300–1Addgene) using Lipofectamine 2000 (Invitrogen). HUVE cells were electropo-
rated with the same constructs using the BTX electroporation kit and an
ECM 830 electroporator machine (settings: 160 V, 20 ms pulse) and then
seeded on 0.8% gelatin-coated coverslips. Immunofluorescence staining
and confocal microscopy were conducted as described previously (Cirone
et al., 2008). The antibody detecting Giantin (ab24586) was obtained from
Abcam, the antibody against protein disulfide isomerase (2446) was from
Cell Signaling, and the antibody targeting GM130 (610822) was obtained
from BD Biosciences.
[3H]Thymidine Incorporation
HEK293T or HUVE cells were seeded onto 96-well plates in growth media at
a density of 3 3 103 cells/well followed by TNP-470 treatments and assess-
ment of [3H]thymidine incorporation as described previously (Hines et al.,
2010).
Endothelial Cell Network Formation
Network formation assays were performed on Matrigel (BD Biosciences)
basement membranes as described previously (Cirone et al., 2008).
Zebrafish Manipulation
Zebrafish (Danio rerio) embryos were collected from natural spawning. cDNA
encoding WT-Rab37, T2E-Rab37, membrane-localized mCherry, or Centrin-
GFP cloned into the pCS2+ expression vector was linearized, and synthetic
RNAs were produced with the mMessage mMachine Capped RNA transcrip-
tion kit (Ambion) using SP6 RNA polymerase. Zebrafish embryos were injected
at the one-cell stage into the yolk with 4–6 nl of 200 ng/ml of each RNA as
described previously (Cirone et al., 2008). Live embryos were photographed
after orienting on 3% methylcellulose. A Zeiss Stereo Discovery.V12 micro-
scope equipped with an AxioVision camera and software was used to acquire
images. For neural tube morphology, live embryos at 28–30 hr postfertilization
were oriented in low-melt agarose and analyzed using a Leica SP2 laser
confocal microscope system with 633 magnification and 23 zoom. Images
are representative of maximum projections of six focal planes (Z series).
Statistical Analysis
Data analysis was conducted using Prism v4.0b software (GraphPad Soft-
ware). Student’s t test and one- or two-way ANOVA analysis were conducted
as appropriate.
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